Clinical and Translational Medicine (Aug 2021)
New strategy for suppressing the growth of lung cancer cells harboring mutations in the ATP‐binding region of EGFR by targeting the molecular motor MYO1D
Abstract
No abstracts available.
Clinical and Translational Medicine (Aug 2021)